Tampons do not contain bacteria or toxins, yet they set the stage for a rare but dangerous chain reaction: a common skin bacterium already living in the vagina multiplies on the tampon, produces a powerful toxin, and that toxin hijacks the immune system into attacking the body’s own organs. The process depends on several factors lining up at once, which is why menstrual toxic shock syndrome (TSS) strikes so few people despite billions of tampons being used every year. Understanding each link in the chain explains both why the risk exists and why it remains small.
The Bacterium That Starts It All
The organism behind menstrual TSS is Staphylococcus aureus, often called staph. It lives harmlessly on the skin and mucous membranes of a large portion of the population. Vaginal colonization is common: a study of 737 healthy tampon-using women found that about 27% of recovered tampons carried S. aureus, and roughly 4% carried a strain capable of producing the specific toxin linked to TSS, known as toxic shock syndrome toxin-1 (TSST-1).1PubMed Central. Vaginal Tampon Colonization by Staphylococcus aureus in Healthy Women Earlier research had placed overall vaginal S. aureus colonization closer to 5%, with about 1% carrying toxin-producing strains.2PubMed. The epidemiology of genital colonization with Staphylococcus aureus The numbers vary across studies, but the core point holds: most women who carry toxin-producing staph never develop TSS. The bacterium is necessary but not sufficient on its own.
How a Tampon Changes the Vaginal Environment
Under normal conditions the vagina is a low-oxygen, acidic space, and both of those features work against S. aureus toxin production. A tampon disrupts both conditions at once.
When a tampon is inserted, it introduces a pocket of trapped air. Measurements taken in the 1980s showed that vaginal oxygen levels jumped to near atmospheric levels immediately after insertion and stayed elevated for roughly 90 minutes before gradually returning toward baseline over about eight hours.3PubMed. Tampon-induced changes in vaginal oxygen and carbon dioxide tensions Since TSST-1 production by S. aureus increases in the presence of oxygen, this shift matters. Every time you remove a tampon and insert a fresh one, the oxygen clock resets.
The pH shift is equally important. A healthy vaginal environment sits at a pH of roughly 3.5 to 4.5, maintained largely by Lactobacillus bacteria that produce lactic acid. During menstruation the pH naturally rises toward neutral as menstrual blood (which is close to pH 7) enters the vaginal canal. Tampons soaked with menstrual fluid show a pH of approximately 7.4PubMed Central. Staphylococcus aureus Exotoxins Are Present In Vivo in Tampons Lab research has confirmed that as pH rises toward neutral, S. aureus ramps up TSST-1 production dramatically. At lower, more acidic pH levels, toxin gene expression drops off.5PubMed Central. Elucidating the Staphylococcus aureus TSST-1 Regulatory Network as a Response to Vaginal pH So a tampon soaked in menstrual blood provides both the neutral pH and the oxygen boost that S. aureus needs to churn out its most dangerous product.
What TSST-1 Does to the Immune System
TSST-1 belongs to a class of molecules called superantigens, and the name is apt. A normal immune response involves a tiny fraction of your T cells recognizing a specific invader. TSST-1 skips that specificity entirely. It latches directly onto immune cells in a way that activates up to 20% of all T cells at once, regardless of what those T cells were designed to fight.6PubMed Central. Toxic Shock Syndrome Toxin-1 (TSST-1) in Staphylococcus aureus: Prevalence, Molecular Mechanisms, and Public Health Implications For comparison, a normal immune response might engage a fraction of a percent of T cells.
The result is a flood of inflammatory signaling molecules. Lab studies using rabbit models have measured some of these signals spiking by thousands of fold. In one experiment, a key inflammatory marker called IL-6 rose over 3,000-fold, while IFN-gamma increased about 870-fold.7PubMed Central. Staphylococcal Superantigen (TSST-1) Mutant Analysis Reveals that T Cell Activation Is Required for Biological Effects in the Rabbit Including the Cytokine Storm This overwhelming release of inflammatory chemicals is what causes the symptoms of TSS: the sudden high fever, plummeting blood pressure, organ stress, rash, and the feeling of being desperately ill within hours. It is your own immune system, not the bacteria itself, doing most of the damage.
A published case report illustrates how quickly this cascade can spiral. A 23-year-old woman arrived at the emergency department with fever, headache, muscle pain, and watery diarrhea that had started only the day before. Her blood pressure had already dropped to 81/37, her heart rate was 132, and her kidneys and liver were showing signs of failure.8PubMed Central. Menstrual toxic shock syndrome That speed is characteristic of superantigen-driven illness. Because so many T cells activate at once, the body can go from feeling fine to critically ill in under 24 hours.
Why Wearing a Tampon Longer Raises the Risk
A French study comparing women who developed menstrual TSS with matched controls found that wearing a tampon for more than six consecutive hours roughly doubled the odds of developing the syndrome. Wearing a tampon overnight for more than eight hours tripled the odds.9PubMed Central. Association of characteristics of tampon use with menstrual toxic shock syndrome in France The same study found that women who neither read nor followed the tampon package instructions had about twice the odds of developing TSS compared with those who did.
The mechanism behind the time factor ties back to the environmental changes described earlier. Every hour a tampon stays in place, S. aureus has more time to multiply and produce toxin in a warm, nutrient-rich, near-neutral pH environment. Changing tampons more frequently does not eliminate the risk, but it reduces the total window of toxin accumulation. That said, the study did not find that tampon absorbency level was independently associated with TSS risk in the modern era, a finding that surprised some researchers given the historical link between high-absorbency products and the original TSS epidemic of the early 1980s.
The Rely Tampon and the 1980s Epidemic
The spike in TSS cases that brought the syndrome to public attention was closely tied to a specific product: Procter & Gamble’s Rely tampon, introduced in 1980. Rely was designed for maximum absorbency using synthetic materials. Its core contained foam cubes and a gelling agent called carboxymethylcellulose encased in a polyester pouch. The gelled material essentially functioned like a growth medium in a lab dish, providing a viscous surface on which bacteria could thrive, and the foam cubes added extra surface area for colonization.10PubMed Central. Rely and Toxic Shock Syndrome: A Technological Health Crisis
After the CDC linked Rely to an outsized share of TSS cases, the product was voluntarily recalled in September 1980. The episode prompted regulators to require standardized absorbency labeling on tampon packaging, a process eventually governed by ASTM International.11Catalyst: Feminism, Theory, Technoscience. Toxic Shock Syndrome, Tampon Absorbency, and Feminist Science The aftermath also kicked off decades of research into whether the composition of modern tampons (cotton versus rayon versus blends) mattered. Early suspicion fell on the carboxymethylcellulose in Rely specifically, but follow-up experiments found that vaginal microbes could not actually break down that material in the way originally hypothesized, raising questions about the precise mechanism by which Rely was more dangerous.12PubMed Central. Application of cross-linked carboxymethyl cellulose degradation by beta-glucosidase and vaginal microbes to toxic shock syndrome
The Cotton Versus Rayon Myth
One persistent belief is that all-cotton tampons are inherently safer than those made with rayon or cotton-rayon blends. This idea has driven an entire market segment of “organic” tampons marketed partly on the premise that natural fibers reduce TSS risk. The lab evidence does not support it.
Controlled experiments comparing all-cotton tampons and cotton-rayon blends found that under both heavily saturated and partially saturated conditions, cotton tampons produced the same amount of or more TSST-1 than blended tampons.13PubMed. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin A separate study confirmed that neither cotton nor rayon consistently increased toxin production and that the differences between them were not significant.14PubMed. Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro Earlier work even found that most tampon materials, with the exception of a couple of rayon samples, actually reduced bacterial growth rates compared to controls in broth culture.15PubMed. Effects of tampon materials on the in-vitro physiology of a toxic shock syndrome strain of Staphylococcus aureus
There may be valid reasons to choose organic cotton products, but a lower risk of TSS is not among them based on current evidence. The factors that matter more are how long you wear the tampon and whether toxin-producing staph happens to be present.
Why Most People Never Get TSS
Given that millions of people use tampons during every menstrual cycle, the rarity of TSS demands an explanation. Several layers of protection exist.
The first is simple microbiology. Only a fraction of S. aureus strains produce TSST-1. You need to be colonized with one of those specific strains, which most people are not.
The second is immunity. Most adults carry antibodies against TSST-1, built up from low-level exposures over a lifetime. Research has shown that these anti-superantigen antibodies can suppress T-cell activation and protect against TSS in animal models.16PubMed Central. Toxic Shock Syndrome Toxin-1-Mediated Toxicity Inhibited by Neutralizing Antibodies Late in the Course of Continual in Vivo and in Vitro Exposure People who lack adequate antibody levels, often younger women who have not yet developed protective titers, are the ones most vulnerable. This helps explain why TSS disproportionately affects adolescents and young adults.
The third layer is the vaginal microbiome itself. Lactobacillus species, the dominant healthy vaginal bacteria, actively work against S. aureus. Lab experiments have found that Lactobacillus rhamnosus did not kill S. aureus directly but did suppress TSST-1 production, partly by keeping the environment acidic. Lactobacillus acidophilus went further, killing S. aureus outright through a combination of acidification, hydrogen peroxide production, and other antimicrobial molecules.17PubMed Central. Inhibition of Toxic Shock Syndrome-Associated Staphylococcus aureus by Probiotic Lactobacilli A broader survey of 39 Lactobacillus strains found that nearly all of them inhibited TSS-associated S. aureus, and the mechanism was strongly tied to the acidification that Lactobacillus is known for.18Anaerobe. Lactobacillus-mediated inhibition of clinical toxic shock syndrome Staphylococcus aureus strains and its relation to acid and peroxide production
Clinical vaginal samples tell a consistent story: samples from both healthy women and women with bacterial vaginosis suppressed toxin production.19PubMed Central. Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus The intact vaginal community acts as a natural brake on TSST-1 output. Disruptions to that community, whether from antibiotics, douching, or shifts during menstruation, can loosen the brake.
TSS Is Not Limited to TSST-1
While TSST-1 gets the most attention, it is not the only toxin capable of triggering toxic shock syndrome. Over 90% of S. aureus strains isolated from TSS patients produce TSST-1, but roughly 60% also produce one or more staphylococcal enterotoxins. In some cases, particularly non-menstrual TSS from wound infections or surgical sites, enterotoxin B alone appears to be the culprit.20PubMed Central. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome These enterotoxins can produce many of the same symptoms in animal models. For menstrual TSS specifically, TSST-1 remains the dominant player, but the existence of alternative toxins means that diagnostic approaches focusing exclusively on TSST-1 could miss some cases.
Are Menstrual Cups Any Safer
The growing popularity of menstrual cups has raised a natural question: do they avoid the TSS problem entirely? The answer is no. At least one confirmed case of TSS associated with a menstrual cup has been published, occurring in a 37-year-old woman using a cup for the first time.21PubMed Central. A confirmed case of toxic shock syndrome associated with the use of a menstrual cup
Lab testing comparing 11 types of tampons and 4 types of menstrual cups found that cups actually produced higher levels of both S. aureus growth and TSST-1 production than tampons did. The researchers attributed this partly to the additional air that cups introduce into the vaginal space, and they observed differences based on cup composition and size.22PubMed Central. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro A narrative review concluded that while TSS incidents with cups are exceedingly rare and cups appear safe with proper hygiene, they are not inherently risk-free and require similar precautions to tampons.23Current Womens Health Reviews. Is There a Risk of Developing Toxic Shock Syndrome and Vaginal Infections by Using a Menstrual Cup? A Narrative Review
The same principles apply: a menstrual cup introduces air, holds menstrual blood at a neutral pH, and sits in the body for extended periods. If toxin-producing S. aureus is present and the user lacks protective antibodies, the cup provides conditions under which toxin can accumulate. Sterilizing cups between uses and following wear-time guidelines matter for the same reasons that tampon change frequency matters.
How Menstrual TSS Is Treated
Treatment starts with removing the tampon or menstrual product immediately and administering aggressive intravenous fluids to counteract the plummeting blood pressure. Antibiotics follow, typically targeting S. aureus while also including agents like clindamycin that specifically inhibit bacterial toxin production rather than just killing the organism.
In severe cases, particularly streptococcal toxic shock syndrome (which involves a different bacterium but a similar superantigen mechanism), intravenous immunoglobulin (IVIG) has been used. A meta-analysis found that adding IVIG to clindamycin-based treatment reduced mortality from about 34% to about 16% in streptococcal TSS.24PubMed. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis IVIG works by flooding the bloodstream with pooled antibodies from thousands of donors, including antibodies that can neutralize superantigens. Its use in staphylococcal menstrual TSS specifically is less well studied in controlled trials, but the biological rationale is strong given that the absence of anti-TSST-1 antibodies is a key vulnerability in patients who develop the syndrome.
The Acidic Virulence Surge
One recent finding complicates the otherwise tidy story of “acid is protective, neutral pH is dangerous.” While TSST-1 production does fall as pH drops from neutral toward acidic conditions, researchers discovered a surprising spike in toxin gene expression at pH 4.5, which they dubbed the “acidic virulence surge.”5PubMed Central. Elucidating the Staphylococcus aureus TSST-1 Regulatory Network as a Response to Vaginal pH This pH sits right at the lower boundary of a healthy vaginal environment. The authors noted that while bacterial growth is limited at this acidity, the unexpected jump in virulence gene activity is potentially significant. S. aureus can still express toxin genes even under conditions that slow its multiplication. The practical implications are still being worked out, but it suggests the relationship between vaginal acidity and TSS risk is not as straightforwardly protective as older models assumed.
Separately, genetic research into how S. aureus regulates TSST-1 production has revealed a layered system of internal controls. A regulatory network involving a gene system called agr and a protein called Rot acts as a molecular switch. When the bacterial population reaches a certain density, agr activity rises, Rot protein gets suppressed, and TSST-1 production increases. When Rot is overproduced, it binds directly to the TSST-1 gene promoter and shuts toxin production down.25PubMed. Regulation of toxic shock syndrome toxin-1 by the accessory gene regulator in Staphylococcus aureus is mediated by the repressor of toxins Understanding these internal controls could eventually lead to new ways of blocking toxin production without needing to kill the bacteria, but that remains a research frontier rather than a clinical reality.